Indegene Limited — Investor Meet, 04-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

Indegene Limited reported Q2 FY '25 revenue of INR 6,868 million, reflecting an 8% year-on-year growth. The enterprise segments drove this increase, with ongoing positive trends noted among major customers. The cash position remains strong with INR 1,467 crores. The company anticipates further growth as the global life sciences industry recovers, with increased outsourcing opportunities. Management emphasizes their strategic positioning for potential expansion through ongoing client engagements and digital solutions integration.